HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MDL 29311

structure given in first source

Also Known As:

4,4'-(methylenebis(thio))bis(2,6-bis(1,1-dimethylethyl))phenol; MDL 29,311; MDL-29311

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Probucol: 701
        MDL 29311: 2

Related Diseases

1.	Atherosclerosis 09/01/1991 - "Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol."
2.	Hypoglycemia (Reactive Hypoglycemia) 08/01/1993 - "In STZ-induced (65 mg/kg) diabetic rats, MDL 29311 attenuated the increase in plasma nonesterified fatty acids during an 18-h fast; had little or no effect on glucagon, pyruvate, lactate, beta-hydroxybutyrate, acetoacetate, or cholesterol; and did not induce hypoglycemia in rats fasted up to 64 h. "

Related Drugs and Biologics

1.	Cholesterol
2.	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)
3.	Lactic Acid (Lactate)
4.	Pyruvic Acid (Pyruvate)
5.	Probucol (Lorelco)
6.	Glucagon (Glukagon)
7.	Nonesterified Fatty Acids (NEFA)
8.	acetoacetic acid (acetoacetate)